ClinicalTrials.Veeva

Menu

Nutritional Therapy in Patients With Post-extubation Dysphagia

N

National Institute of Respiratory Diseases, Mexico

Status

Enrolling

Conditions

Dysphagia

Treatments

Other: Usual protein dose
Other: High protein dose

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

The aim of this study is to evaluate the impact of the prescription of two doses of protein on the amount in kilograms of muscle mass and on the clinical evolution (time until safe swallowing, time until removal of the feeding stoma, number of hospital readmissions, feeding stoma infections, incidence of pneumonia, functionality, number of falls, fractures and mortality) at 6 months after hospital discharge in patients with enteral nutrition due to post-extubation dysphagia.

Enrollment

128 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients who required invasive mechanical ventilation during their hospital stay with a diagnosis of post-extubation dysphagia diagnosed by fibroendoscopy evaluation of swallowing (FEES).
  • Patients who discharged with a feeding tube.
  • Patients with signed informed consent.

Exclusion criteria

  • Patients with pre-existing dysphagia, or with neurological conditions that can cause dysphagia (e.g. multiple sclerosis, Parkinson's disease, Alzheimer's, myasthenia gravis).
  • Patients with chronic kidney disease, defined as a glomerular filtration rate <60 ml/min.
  • Patients discharged with a terminal condition and/or life expectancy of less than 3 months.
  • Diagnosis of HIV, upon receiving clinical follow-up by the team of specialists.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

128 participants in 2 patient groups

High protein group
Experimental group
Description:
100% of the energy requirements measured by indirect calorimetry (IC) or estimated, and a protein intake of 2.0 g/kg, will be prescribed
Treatment:
Other: High protein dose
Usual protein group
Other group
Description:
100% of the energy requirements measured by IC or estimated, and a protein intake of 1.5 g/kg, will be prescribed.
Treatment:
Other: Usual protein dose

Trial contacts and locations

1

Loading...

Central trial contact

Ivan A Osuna-Padilla, PhD; Alan Garcia-Grimaldo, MSc

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems